Síndrome inflamatorio multisistémico en un adulto secundario a infección por SARS-CoV-2. Reporte de caso

Recent reports describe multisystemic inflammation syndrome in children after COVID-19 infection, who have presented features of Kawasaki disease. Few cases have been reported of this entity in adults, but it has been observed in patients after exposure to SARS-CoV-2. The following case describes a 27-year-old male patient, with a history of previous COVID 19 infection diagnosed with the COVID 19 RT-PCR test, who presented with diarrhoeal stools, nausea, vomiting, febrile process, haemodynamic instability, and respiratory failure. The physical examination revealed a conjunctival injection in both eyes and a rash in the upper limbs. Laboratory tests demonstrated an infectious and inflammatory process. Findings of an inflammatory disorder similar to Kawasaki disease, with previous exposure to SARS-CoV-2, and with good response to treatment with human immunoglobulin (IVIG), steroid, and tocilizumab. Reporting these clinical cases alerts the medical scientific community to always have clinical suspicion and apply the diagnostic criteria established by the CDC for adult patients, thus prompt treatment is established for these patients. To the best of our knowledge, we present the first case of multisystemic inflammatory syndrome in adults secondary to SARS-CoV-2 infection in El Salvador.